These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 27989322

  • 1. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodríguez de Córdoba S, Roumenina LT, Sethi S, Smith RJ, Conference Participants.
    Kidney Int; 2017 Mar; 91(3):539-551. PubMed ID: 27989322
    [Abstract] [Full Text] [Related]

  • 2. Complement Inhibitors in Clinical Trials for Glomerular Diseases.
    Zipfel PF, Wiech T, Rudnick R, Afonso S, Person F, Skerka C.
    Front Immunol; 2019 Mar; 10():2166. PubMed ID: 31611870
    [Abstract] [Full Text] [Related]

  • 3. Evolving complexity of complement-related diseases: C3 glomerulopathy and atypical haemolytic uremic syndrome.
    Cook HT.
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):165-170. PubMed ID: 29517501
    [Abstract] [Full Text] [Related]

  • 4. Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice.
    Smith-Jackson K, Yang Y, Denton H, Pappworth IY, Cooke K, Barlow PN, Atkinson JP, Liszewski MK, Pickering MC, Kavanagh D, Cook HT, Marchbank KJ.
    J Clin Invest; 2019 Mar 01; 129(3):1061-1075. PubMed ID: 30714990
    [Abstract] [Full Text] [Related]

  • 5. Complete functional characterization of disease-associated genetic variants in the complement factor H gene.
    Merinero HM, García SP, García-Fernández J, Arjona E, Tortajada A, Rodríguez de Córdoba S.
    Kidney Int; 2018 Feb 01; 93(2):470-481. PubMed ID: 28941939
    [Abstract] [Full Text] [Related]

  • 6. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ, Breno M, Borsa NG, Bu F, Frémeaux-Bacchi V, Gale DP, van den Heuvel LP, Kavanagh D, Noris M, Pinto S, Rallapalli PM, Remuzzi G, Rodríguez de Cordoba S, Ruiz A, Smith RJH, Vieira-Martins P, Volokhina E, Wilson V, Goodship THJ, Perkins SJ.
    J Immunol; 2018 Apr 01; 200(7):2464-2478. PubMed ID: 29500241
    [Abstract] [Full Text] [Related]

  • 7. A case of atypical hemolytic uremic syndrome in a second renal transplant.
    Zwang NA, Ho B, Kanwar YS, Lewis B, Cusick M, Friedewald JJ, Gallon L.
    J Nephrol; 2018 Feb 01; 31(1):165-172. PubMed ID: 28224376
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
    Józsi M, Reuter S, Nozal P, López-Trascasa M, Sánchez-Corral P, Prohászka Z, Uzonyi B.
    Immunol Lett; 2014 Aug 01; 160(2):163-71. PubMed ID: 24491679
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Atypical hemolytic uremic syndrome and complement blockade: established and emerging uses of complement inhibition.
    Hanna RM, Barsoum M, Vandross A, Kurtz I, Burwick R.
    Curr Opin Nephrol Hypertens; 2019 May 01; 28(3):278-287. PubMed ID: 30865166
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C, Verhave JC, Berger SP, van de Kar NCAJ, Wetzels JFM.
    Am J Kidney Dis; 2017 Dec 01; 70(6):770-777. PubMed ID: 28821363
    [Abstract] [Full Text] [Related]

  • 20. Complement-mediated kidney diseases.
    Poppelaars F, Thurman JM.
    Mol Immunol; 2020 Dec 01; 128():175-187. PubMed ID: 33137606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.